EUVIMEDEUVIMED entdecken
Crossref

Exploring the anticancer potentials of canavalia virosa (roxb) wight &arn ethanol extract against in vitro and in vivo animal model

C. Bhuvaneswari, R. Sivasubramanian, G. Sridharan

International Journal of Drug Delivery Technology · 06.07.2026 · 16 (62s)

DOI: 10.25258/ijddt.16.62s.47 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Drug Delivery Technology, online erschienen am 06.07.2026. Verfasst von C. Bhuvaneswari und 2 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

Cancer is a heterogeneous group of diseases that is characterized by unrestrained growth. It is a diverse set of disorders characterized by unrestrained cellular proliferation, local invasion, and distant metastasis, and is one of the most important problems in modern medicine. Methodology: Medicinal flora represents an abundant source of bioactive metabolites, and many successful antineoplastic agents have been obtained from plant-derived phytochemical substances. The Fabaceae family haslisted several sizable anticancer constituents. Accordingly, Kattuthampattan, which botanically is Canavalia virosa ( Roxb.), was selected for the present study.Wight &Arn, evaluation of its antioxidant & antitumor activity against Ehrlich Ascites Carcinoma (EAC).

Results

Preliminary research for phytochemicals of the ethanolic extract of C. virosa (EECV) revealed the presence of tannins, alkaloids, flavonoids, phenols, and saponins; quantitative determination showed the presence of alkaloids in high and significant amounts. The in vitro antioxidant potential was assessed using DPPH, ABTS, and reducing power measures, all of which demonstrated good free radical scavenging activity. Cytotoxic and antiproliferative activities against EAC cells were determined using trypan blue exclusion, MTT, LDH, and DNA fragmentation test. EECV showed dose-related cytotoxicity and caused apoptosis in the tumour cells. In vivo antitumor efficacy using an experimental model of cancer in Swiss albino mice with EAC was studied. Treatment with EECV (150 and 300 mg/kg of body weight) for 14 days caused a significant decrease in ascitic tumour volume, viable tumour cell count, nucleic acid and glycoprotein concentrations, and reversed the altered hematological and antioxidant profiles. Furthermore, EECV significantly increased the survival of tumour-bearing mice, effects commensurate with those of a standard chemotherapeutic agent, 5-fluorouracil.

Conclusion

These data collectively show evidence that the ethanolic extract of Canavalia virosa harbours potent antioxidant, cytotoxic, and antitumour activities, thus the potential of this medicinal plant as a natural anticancer therapeutic.

Zitieren

APA

Bhuvaneswari, C., Sivasubramanian, R., & Sridharan, G. (2026). Exploring the anticancer potentials of canavalia virosa (roxb) wight &arn ethanol extract against in vitro and in vivo animal model. International Journal of Drug Delivery Technology, 16(62s). https://doi.org/10.25258/ijddt.16.62s.47

Vancouver

Bhuvaneswari C, Sivasubramanian R, Sridharan G. Exploring the anticancer potentials of canavalia virosa (roxb) wight &arn ethanol extract against in vitro and in vivo animal model. International Journal of Drug Delivery Technology. 2026;16(62s). doi:10.25258/ijddt.16.62s.47

BibTeX
@article{Bhuvaneswari2026,
  author = {Bhuvaneswari, C. and Sivasubramanian, R. and Sridharan, G.},
  title = {Exploring the anticancer potentials of canavalia virosa (roxb) wight &arn ethanol extract against in vitro and in vivo animal model},
  journal = {International Journal of Drug Delivery Technology},
  year = {2026},
  volume = {16},
  number = {62s},
  doi = {10.25258/ijddt.16.62s.47}
}
Kostenlos starten →